carbachol has been researched along with HIV Coinfection in 2 studies
Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rufo, PA | 1 |
| Lin, PW | 1 |
| Andrade, A | 1 |
| Jiang, L | 1 |
| Rameh, L | 1 |
| Flexner, C | 1 |
| Alper, SL | 1 |
| Lencer, WI | 1 |
| de Bracco, MM | 1 |
| Borda, E | 1 |
| Galassi, N | 1 |
| Perez-Bianco, R | 1 |
| Sterin-Borda, L | 1 |
2 other studies available for carbachol and HIV Coinfection
| Article | Year |
|---|---|
Diarrhea-associated HIV-1 APIs potentiate muscarinic activation of Cl- secretion by T84 cells via prolongation of cytosolic Ca2+ signaling.
Topics: Adult; Aspartic Acid Endopeptidases; Calcium Signaling; Carbachol; Cell Line; Cell Membrane; Chlorid | 2004 |
Autoantibodies in HIV-infected patients that modulate the cholinergic activity of heart and gut tissue.
Topics: Animals; Atropine; Autoantibodies; Carbachol; Heart; HIV Infections; Humans; Immunoglobulins; In Vit | 1993 |